Inhibrx Investors 02

Investors’ Deck

Get the most up-to-date information on Inhibrx.

Review the most recent status on our pipeline progress.

Download deck

Inhibrx, inc. - Report of Organizational Actions Affecting Basis of Securities

On May 29, 2024, Inhibrx, inc. (the “company”) distributed 92% of the issued and outstanding shares of the common stock in its subsidiary, Inhibrx biosciences, inc. (the “subsidiary”) to company’s common shareholders as of the distribution record date, May 17, 2024. The distribution was made on a pro rata basis, at a ratio of one share of the subsidiary’s common stock for every four shares of the company’s issued and outstanding common stock held on the distribution record date.

Shares and ADRs
Inhibrx Block 05

Investor Resources

Board Committees

The grid below provides an overview of the individuals that make up each of Inhibrx’s current committees.

Chair Member
Audit Committee
Compensation Committee
Nominating & Corporate Governance Committee
Douglas G. Forsyth
Jon Faiz Kayyem, Ph.D.
Kimberly Manhard
Kristiina Vuori, M.D., Ph.D.
Inhibrx Block 06

Governance Documents

Our Partners

Learn more

Investor FAQs

On what stock exchange are Inhibrx’s shares traded and what is the ticker symbol?

Inhibrx will trade on the NASDAQ Global Market, temporarily listed under the symbol “INXB” until the completion of the Merger with Sanofi, at which time the ticker symbol will change to “INBX.”

Where is Inhibrx’s corporate headquarters?

11025 North Torrey Pines Road, Suite 140, La Jolla, CA 92037
View on Google Maps

When does Inhibrx’s fiscal year end?

The company’s fiscal year ends on December 31st.

Does Inhibrx pay dividends?

Inhibrx does not expect to declare or pay any cash or other dividends on our common stock.

Does Inhibrx have a direct stock purchase plan?

Inhibrx does not currently have a direct stock purchase plan.

Where can I find all of Inhibrx’s SEC filings? Where can I download and view annual and quarterly reports?

Quarterly and annual reports, as well as other SEC filings, can be accessed via the SEC Filings section on this page or directly from the SEC at www.sec.gov.

Who is Inhibrx’s transfer agent and who do I contact with questions about my stock certificates? How can I contact Inhibrx’s transfer agent?

Continental Stock Transfer & Trust
1 State Street, 30th Floor
New York, NY 10004-1561
[email protected]

Analyst Coverage

Below is a list of individuals that we’re aware of that currently follow Inhibrx. Please note that any opinions, estimates, or forecasts regarding performance made by these analysts don’t represent Inhibrx or its management team.

Firm
Analyst
JMP Securities
Reni J. Benjamin, PhD
Jefferies
Michael J. Yee